Literature DB >> 3948172

Characterization of alterations in plasma lipoprotein lipid and apoprotein profiles accompanying hepatoma-induced hyperlipidemia in rats.

R W Clark, R C Crain.   

Abstract

Alterations in plasma lipoprotein lipid and apoprotein accompanying the hyperlipidemia of rats bearing Morris hepatoma 7288C were characterized. In tumor-bearing animals all plasma lipid classes except cholesterol ester (CE) were elevated, particularly free cholesterol (FC) and triglyceride (TG), which increased by 57 and 63%, respectively. Fasting only partially reduced the tumor-induced hyperlipidemia and had no effect on the ratios of FC/CE and TG/CE. Analysis of plasma lipoproteins revealed an elevation of VLDL, IDL, and LDL in host rats, with more than a 2-fold increase in both lipid and protein of VLDL. In contrast, the three high density fractions, HDL2, HDL3, and d greater than 1.21 g/ml, were reduced. The inverse changes in concentration of host lipoproteins of lower versus higher density indicate a defective catabolism of TG-rich lipoprotein. This possibility is supported by the analysis of apolipoprotein. The percentage of total apoprotein contributed by apo C-I and C-II was reduced in all host fractions except HDL2, while the C-IIIs remained unchanged except for a small decrease in C-III-3 of host VLDL and a slight increase in the combined C-IIIs of HDL2. These changes were reflected in the decreased C-I+C-II/C-III ratios of all host lipoprotein fractions. Apo E levels remained similar to control values except for a significant decrease in HDL2. Host VLDL showed increased apo A-IV and A-I content, while A-IV was decreased in HDL2. Changes in apo B profiles were also observed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3948172

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  The preferential uptake of very-low-density lipoprotein cholesteryl ester by rat liver in vivo.

Authors:  J C Holder; V A Zammit; D S Robinson
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

2.  Suppression of hypercholesterolemia in hepatoma-bearing rats by cabbage extract and its component, S-methyl-L-cysteine sulfoxide.

Authors:  W Komatsu; Y Miura; K Yagasaki
Journal:  Lipids       Date:  1998-05       Impact factor: 1.880

3.  Effects of dietary methionine and cystine on lipid metabolism in hepatoma-bearing rats with hyperlipidemia.

Authors:  M Kawasaki; R Funabiki; K Yagasaki
Journal:  Lipids       Date:  1998-09       Impact factor: 1.880

4.  Analysis of some metabolic conditions promoting selective sensitivity of tumor cells to peroxidative stress.

Authors:  P M Schwartzburd; K B Aslanidi
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

5.  Reduction of hyperlipidemia in hepatoma-bearing rats by dietary fish oil.

Authors:  M Kawasaki; K Yagasaki; Y Miura; R Funabiki
Journal:  Lipids       Date:  1995-05       Impact factor: 1.880

6.  Effect of Terminalia catappa on lipid profile in transplanted fibrosarcoma in rats.

Authors:  Pandya Naitik; Tigari Prakash; Dupadahalli Kotresha; Nadendla Rama Rao
Journal:  Indian J Pharmacol       Date:  2012-05       Impact factor: 1.200

7.  Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).

Authors:  S Dessì; B Batetta; O Spano; G J Bagby; L Tessitore; P Costelli; F M Baccino; P Pani; J M Argilès
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.